Peru has had more COVID-related deaths per capita than any other country. Given its “relative wealth” as an Upper Middle Income Country, Peru did not receive many COVID vaccine donations through COVAX, and Peru’s challenges in directly negotiating for vaccines with pharmaceutical companies delayed the country’s initial response. Peru’s COVID challenges and successes offer lessons for the scale-up of vaccination programs, health innovations, and future pandemic response measures. This thesis explores national, regional, and global barriers and enablers of Peru’s COVID-19 pandemic response, particularly for timely and effective COVID-19 vaccine procurement and distribution and intends to offer policy recommendations to improve pandemic preparedness at local and global levels. Spanish and English semi-structured in-depth interviews were conducted in Lima, Peru in-person and over Zoom with 35 individuals involved in Peru’s pandemic response in public, private, academia, healthcare, and civil society sectors. A qualitative content analysis is currently being done on the interviews, afterwards a force field analysis will be applied to the findings to understand factors that negatively and positively impacted Peru’s pandemic response capacity.